US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

The Aaron's Company, Inc.

10.09

0.0000

Volume:- -

Turnover:- -

Market Cap:309.89M

PE:-7.25

High:10.09

Open:10.09

Low:10.09

Close:10.09

52wk High:11.90

52wk Low:6.62

Shares:30.71M

Float Shares:29.87M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.50

Dividend Rate:4.96%

EPS(TTM):-1.3911

EPS(LYR):0.0917

ROE:-6.22%

ROA:2.18%

PB:0.47

PE(LYR):110.01

Loading ...

Overview Company News Filings

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After New Neurology Data Plans At 2026 AAN Meeting

Simply Wall St.

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

Xenon to Unveil Phase 3 Azetukalner Data and Pipeline Advances at 2026 AAN Meeting

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

Press Release: AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Fundamental Research Sticks to Their Buy Rating for Aton Resources (AAN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AAN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAN\",,,,,undefined,":{"symbol":"AAN","market":"US","secType":"STK","nameCN":"The Aaron's Company, Inc.","latestPrice":10.09,"timestamp":1783627200000,"preClose":10.09,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":29872074,"shares":30712772,"eps":-1.391109,"marketStatus":"Not Yet Opened","change":0,"latestTime":"07-09 16:00:00 EDT","open":10.09,"high":10.09,"low":10.09,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.391109,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785225600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":10.09,"dividendRate":0.049554,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAN\",,,,,undefined,":{"symbol":"AAN","floatShares":29872074,"roa":"2.18%","roe":"-6.22%","lyrEps":0.091721,"shares":30712772,"dividePrice":0.5,"high":10.09,"amplitude":0,"preClose":10.09,"low":10.09,"week52Low":6.622,"pbRate":"0.47","psRate":"0.15","week52High":11.9,"institutionHeld":0.9259,"latestPrice":10.09,"eps":-1.391109,"divideRate":0.049554,"volume":0,"delay":0,"ttmEps":-1.391109,"open":10.09,"prevYearClose":10.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-10-04","symbol":"AAN","reason":null,"defaultRemindTime":1728048600000,"announcedDate":"2024-09-20","type":"delisting","dateTimestamp":1728014400000},{"date":"2024-09-13","symbol":"AAN","amount":0.125,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-13","defaultRemindTime":1726234200000,"name":"The Aaron's Company, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-03","payableDate":"2024-09-13","currency":"USD","dateTimestamp":1726200000000,"payDate":"2024-10-03"},{"date":"2024-08-05","symbol":"AAN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":0.03,"defaultRemindTime":1722888000000,"name":null,"time":"Post Market","dateTimestamp":1722830400000,"actualEps":null},{"date":"2024-06-14","symbol":"AAN","amount":0.125,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-06-14","defaultRemindTime":1718371800000,"name":"The Aaron's Company, Inc.","recordDate":"2024-07-03","payableDate":"2024-06-14","currency":"USD","dateTimestamp":1718337600000,"payDate":"2024-07-03"},{"date":"2024-05-06","symbol":"AAN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":-0.08,"defaultRemindTime":1715025600000,"name":null,"time":"Post Market","dateTimestamp":1714968000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAN\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-13","recordDate":null,"paymentDate":null,"value":0.0275,"currency":"USD"},{"executeDate":"2017-06-23","recordDate":null,"paymentDate":null,"value":0.0275,"currency":"USD"},{"executeDate":"2017-09-14","recordDate":null,"paymentDate":null,"value":0.0275,"currency":"USD"},{"executeDate":"2017-12-12","recordDate":null,"paymentDate":null,"value":0.03,"currency":"USD"},{"executeDate":"2018-03-22","recordDate":null,"paymentDate":null,"value":0.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":7,"updateTime":1720670400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAN","date":"2024-10-02","current":-7.253206,"percent":0.311436,"low":-226.61145,"twenty":-13.023365,"median":6.536302,"eighty":20.725985,"high":112.497555,"avg":-0.454661,"sd":44.674017,"marketCap":304670698},"quantilePoints":[{"date":"2021-07-30","current":9.001746,"twenty":-9.75604,"median":11.175949,"eighty":14.583366,"marketCap":943256951},{"date":"2021-08-06","current":8.621347,"twenty":-9.731195,"median":11.141484,"eighty":14.569104,"marketCap":903396422},{"date":"2021-08-13","current":9.117113,"twenty":-9.719216,"median":10.680732,"eighty":14.542881,"marketCap":955345800},{"date":"2021-08-20","current":8.764776,"twenty":-9.702358,"median":10.238148,"eighty":14.515087,"marketCap":918425802},{"date":"2021-08-27","current":8.602638,"twenty":-9.686386,"median":10.004734,"eighty":14.503803,"marketCap":901436068},{"date":"2021-09-03","current":8.371904,"twenty":-9.670858,"median":9.878227,"eighty":14.495035,"marketCap":877258370},{"date":"2021-09-10","current":8.178587,"twenty":-9.661985,"median":9.724994,"eighty":14.487674,"marketCap":857001379},{"date":"2021-09-17","current":8.396849,"twenty":-9.651781,"median":9.151412,"eighty":14.481233,"marketCap":879872175},{"date":"2021-09-24","current":8.580812,"twenty":-9.63226,"median":9.001746,"eighty":14.46099,"marketCap":899148988},{"date":"2021-10-01","current":8.761658,"twenty":-9.601647,"median":8.958094,"eighty":14.437068,"marketCap":918099076},{"date":"2021-10-08","current":8.714887,"twenty":-9.542197,"median":8.892615,"eighty":14.434307,"marketCap":913198191},{"date":"2021-10-15","current":8.56834,"twenty":-9.495613,"median":8.813105,"eighty":14.433387,"marketCap":897842086},{"date":"2021-10-22","current":9.447624,"twenty":-9.47343,"median":8.883261,"eighty":14.431087,"marketCap":989978719},{"date":"2021-10-29","current":7.629357,"twenty":-9.434388,"median":8.8209,"eighty":14.420506,"marketCap":736393147},{"date":"2021-11-05","current":8.350215,"twenty":-9.394459,"median":8.792838,"eighty":14.39847,"marketCap":805971123},{"date":"2021-11-12","current":8.568756,"twenty":-9.349649,"median":8.764776,"eighty":14.382391,"marketCap":827064898},{"date":"2021-11-19","current":8.239314,"twenty":-9.109187,"median":8.724241,"eighty":14.37404,"marketCap":795266819},{"date":"2021-11-26","current":7.847898,"twenty":-8.748937,"median":8.714887,"eighty":14.357938,"marketCap":757486922},{"date":"2021-12-03","current":7.440172,"twenty":-8.524445,"median":8.691502,"eighty":14.306872,"marketCap":718132864},{"date":"2021-12-10","current":7.94249,"twenty":-8.467214,"median":8.668117,"eighty":14.283409,"marketCap":766617064},{"date":"2021-12-17","current":7.844636,"twenty":-8.262243,"median":8.662471,"eighty":14.239703,"marketCap":757172090},{"date":"2021-12-23","current":7.988155,"twenty":-8.187709,"median":8.61667,"eighty":14.234182,"marketCap":771024719},{"date":"2021-12-31","current":8.040344,"twenty":-8.054612,"median":8.608874,"eighty":14.21348,"marketCap":776062038},{"date":"2022-01-07","current":7.74352,"twenty":-8.039083,"median":8.604197,"eighty":14.188176,"marketCap":747412283},{"date":"2022-01-14","current":7.489099,"twenty":-7.937042,"median":8.587048,"eighty":14.176675,"marketCap":722855351},{"date":"2022-01-21","current":6.954164,"twenty":-7.711664,"median":8.580812,"eighty":14.163793,"marketCap":671222826},{"date":"2022-01-28","current":6.771503,"twenty":-7.561264,"median":8.568548,"eighty":14.153212,"marketCap":653592207},{"date":"2022-02-04","current":6.774764,"twenty":-7.498708,"median":8.50598,"eighty":14.13849,"marketCap":653907040},{"date":"2022-02-11","current":6.800859,"twenty":-7.4783,"median":8.402672,"eighty":14.109507,"marketCap":656425699},{"date":"2022-02-18","current":6.85631,"twenty":-7.417075,"median":8.390613,"eighty":14.090805,"marketCap":661777851},{"date":"2022-02-25","current":6.0444,"twenty":-7.399772,"median":8.371904,"eighty":14.073473,"marketCap":664485049},{"date":"2022-03-04","current":6.303647,"twenty":-7.338104,"median":8.35837,"eighty":14.046019,"marketCap":692985107},{"date":"2022-03-11","current":6.154298,"twenty":-7.214323,"median":8.322016,"eighty":14.028536,"marketCap":676566596},{"date":"2022-03-18","current":6.531897,"twenty":-7.133134,"median":8.300596,"eighty":14.016575,"marketCap":718077550},{"date":"2022-03-25","current":6.358874,"twenty":-7.012459,"median":8.278364,"eighty":13.990352,"marketCap":699056405},{"date":"2022-04-01","current":5.853417,"twenty":-6.728961,"median":8.262316,"eighty":13.959988,"marketCap":643489564},{"date":"2022-04-08","current":6.111955,"twenty":-4.797768,"median":8.237829,"eighty":13.929624,"marketCap":671911684},{"date":"2022-04-14","current":6.210723,"twenty":-3.54381,"median":8.229529,"eighty":13.89558,"marketCap":682769573},{"date":"2022-04-22","current":5.94928,"twenty":-3.437831,"median":8.209791,"eighty":13.857395,"marketCap":654028103},{"date":"2022-04-29","current":6.626359,"twenty":-3.415191,"median":8.180601,"eighty":13.79395,"marketCap":630451705},{"date":"2022-05-06","current":6.539213,"twenty":-3.410303,"median":8.142587,"eighty":13.634075,"marketCap":622160328},{"date":"2022-05-13","current":6.452066,"twenty":-3.405158,"median":8.086009,"eighty":13.512696,"marketCap":613868951},{"date":"2022-05-20","current":5.864635,"twenty":-3.380718,"median":8.051782,"eighty":13.496451,"marketCap":557978932},{"date":"2022-05-27","current":6.077659,"twenty":-3.349589,"median":8.001202,"eighty":13.451527,"marketCap":578246741},{"date":"2022-06-03","current":5.961464,"twenty":-3.34573,"median":7.971846,"eighty":13.396862,"marketCap":567191572},{"date":"2022-06-10","current":5.796854,"twenty":-3.345215,"median":7.947382,"eighty":13.321166,"marketCap":551530083},{"date":"2022-06-17","current":5.060951,"twenty":-3.339813,"median":7.90661,"eighty":13.254413,"marketCap":481514015},{"date":"2022-06-24","current":5.222333,"twenty":-3.326435,"median":7.860945,"eighty":13.231199,"marketCap":496868416},{"date":"2022-07-01","current":4.760779,"twenty":-3.316144,"median":7.81528,"eighty":13.22259,"marketCap":452954829},{"date":"2022-07-08","current":4.947983,"twenty":-3.305854,"median":7.76146,"eighty":13.21226,"marketCap":470765934},{"date":"2022-07-15","current":4.734958,"twenty":-3.289903,"median":7.704378,"eighty":13.206235,"marketCap":450498125},{"date":"2022-07-22","current":5.167463,"twenty":-3.28553,"median":7.670129,"eighty":13.197004,"marketCap":491647920},{"date":"2022-07-29","current":7.051656,"twenty":-3.278069,"median":7.648928,"eighty":13.194912,"marketCap":400717386},{"date":"2022-08-05","current":7.214136,"twenty":-3.275239,"median":7.552705,"eighty":13.171694,"marketCap":409950505},{"date":"2022-08-12","current":7.907387,"twenty":-3.267779,"median":7.629357,"eighty":13.156156,"marketCap":449345149},{"date":"2022-08-19","current":7.598674,"twenty":-3.244368,"median":7.653821,"eighty":13.131529,"marketCap":431802221},{"date":"2022-08-26","current":6.932503,"twenty":-3.236907,"median":7.598674,"eighty":13.111469,"marketCap":393946432},{"date":"2022-09-02","current":6.428814,"twenty":-3.219927,"median":7.549929,"eighty":13.107841,"marketCap":365323761},{"date":"2022-09-09","current":6.640038,"twenty":-3.21118,"median":7.533133,"eighty":13.099134,"marketCap":377326816},{"date":"2022-09-16","current":6.612958,"twenty":-3.207321,"median":7.484937,"eighty":13.091152,"marketCap":375787963},{"date":"2022-09-23","current":5.8493,"twenty":-3.205263,"median":7.456481,"eighty":13.087524,"marketCap":332392302},{"date":"2022-09-30","current":5.26437,"twenty":-3.201919,"median":7.440172,"eighty":13.068659,"marketCap":299153071},{"date":"2022-10-07","current":5.145217,"twenty":-3.198832,"median":7.301545,"eighty":13.052696,"marketCap":292382117},{"date":"2022-10-14","current":4.798592,"twenty":-3.190085,"median":7.23794,"eighty":13.04544,"marketCap":272684795},{"date":"2022-10-21","current":4.717352,"twenty":-3.17645,"median":7.204836,"eighty":13.012404,"marketCap":268068236},{"date":"2022-10-28","current":18.856739,"twenty":-3.156126,"median":7.23794,"eighty":13.087524,"marketCap":317962337},{"date":"2022-11-04","current":17.72497,"twenty":-3.141719,"median":7.301545,"eighty":13.115097,"marketCap":298878441},{"date":"2022-11-11","current":20.882972,"twenty":-3.13786,"median":7.440172,"eighty":13.194912,"marketCap":352128668},{"date":"2022-11-18","current":20.171052,"twenty":-3.129627,"median":7.456481,"eighty":13.226034,"marketCap":340124281},{"date":"2022-11-25","current":21.138532,"twenty":-3.119851,"median":7.477233,"eighty":13.381747,"marketCap":356437935},{"date":"2022-12-02","current":22.945713,"twenty":-3.112391,"median":7.528241,"eighty":13.634075,"marketCap":386910608},{"date":"2022-12-09","current":21.412348,"twenty":-3.103901,"median":7.549929,"eighty":13.936064,"marketCap":361055006},{"date":"2022-12-16","current":21.722672,"twenty":-3.091295,"median":7.598674,"eighty":14.030377,"marketCap":366287688},{"date":"2022-12-23","current":20.755191,"twenty":-3.086664,"median":7.653821,"eighty":14.122388,"marketCap":349974034},{"date":"2022-12-30","current":21.813943,"twenty":-3.077344,"median":7.683177,"eighty":14.173455,"marketCap":367826712},{"date":"2023-01-06","current":23.821921,"twenty":-3.05859,"median":7.720687,"eighty":14.234182,"marketCap":401685237},{"date":"2023-01-13","current":26.194986,"twenty":-3.050427,"median":7.750322,"eighty":14.369899,"marketCap":441699859},{"date":"2023-01-20","current":25.884662,"twenty":-3.037365,"median":7.785923,"eighty":14.411305,"marketCap":436467178},{"date":"2023-01-27","current":26.158478,"twenty":-2.983948,"median":7.846267,"eighty":14.435227,"marketCap":441084249},{"date":"2023-02-03","current":28.239473,"twenty":-2.934484,"median":7.860945,"eighty":14.492274,"marketCap":476173994},{"date":"2023-02-10","current":26.724362,"twenty":-2.921987,"median":7.903348,"eighty":14.564964,"marketCap":450626197},{"date":"2023-02-17","current":26.92516,"twenty":-2.910286,"median":7.907387,"eighty":14.628911,"marketCap":454012050},{"date":"2023-02-24","current":25.793391,"twenty":-2.891238,"median":7.922919,"eighty":14.647007,"marketCap":434928154},{"date":"2023-03-03","current":-74.11349,"twenty":-2.922804,"median":7.915153,"eighty":14.672386,"marketCap":391319229},{"date":"2023-03-10","current":-64.718823,"twenty":-3.053692,"median":7.907387,"eighty":14.647007,"marketCap":341715383},{"date":"2023-03-17","current":-54.86022,"twenty":-3.100042,"median":7.890196,"eighty":14.635427,"marketCap":289661964},{"date":"2023-03-24","current":-55.522605,"twenty":-3.13786,"median":7.853226,"eighty":14.634482,"marketCap":293159356},{"date":"2023-03-31","current":-58.235436,"twenty":-3.190085,"median":7.835391,"eighty":14.630291,"marketCap":307483103},{"date":"2023-04-06","current":-57.512015,"twenty":-3.205778,"median":7.782661,"eighty":14.622931,"marketCap":303663437},{"date":"2023-04-14","current":-64.62566,"twenty":-3.237936,"median":7.74352,"eighty":14.604068,"marketCap":341223485},{"date":"2023-04-21","current":-62.214255,"twenty":-3.281671,"median":7.694593,"eighty":14.584286,"marketCap":328491265},{"date":"2023-04-28","current":-29.179552,"twenty":-3.322319,"median":7.658713,"eighty":14.573245,"marketCap":408922246},{"date":"2023-05-05","current":-26.224103,"twenty":-3.349589,"median":7.614015,"eighty":14.548861,"marketCap":367504573},{"date":"2023-05-12","current":-27.701827,"twenty":-3.415191,"median":7.555345,"eighty":14.520365,"marketCap":388213410},{"date":"2023-05-19","current":-28.650218,"twenty":-6.80039,"median":7.533133,"eighty":14.504046,"marketCap":401504155},{"date":"2023-05-26","current":-27.282771,"twenty":-7.358069,"median":7.484937,"eighty":14.497795,"marketCap":382340755},{"date":"2023-06-02","current":-27.018104,"twenty":-7.486286,"median":7.459743,"eighty":14.488594,"marketCap":378631709},{"date":"2023-06-09","current":-31.782113,"twenty":-8.018675,"median":7.446307,"eighty":14.483074,"marketCap":445394525},{"date":"2023-06-16","current":-30.017665,"twenty":-8.467214,"median":7.348842,"eighty":14.468351,"marketCap":420667556},{"date":"2023-06-23","current":-28.716385,"twenty":-9.312382,"median":7.241202,"eighty":14.438908,"marketCap":402431417},{"date":"2023-06-30","current":-31.605668,"twenty":-9.459233,"median":7.224968,"eighty":14.435227,"marketCap":442921828},{"date":"2023-07-07","current":-31.892391,"twenty":-9.591,"median":7.195537,"eighty":14.434307,"marketCap":446939961},{"date":"2023-07-14","current":-33.083393,"twenty":-9.670858,"median":7.136824,"eighty":14.432927,"marketCap":463630665},{"date":"2023-07-21","current":-34.340562,"twenty":-9.731195,"median":7.111232,"eighty":14.430627,"marketCap":481248630},{"date":"2023-07-28","current":-33.921505,"twenty":-9.803955,"median":7.051837,"eighty":14.415905,"marketCap":475375975},{"date":"2023-08-04","current":-188.365396,"twenty":-9.879821,"median":7.029992,"eighty":14.394353,"marketCap":405927428},{"date":"2023-08-11","current":-189.224858,"twenty":-9.963672,"median":6.998198,"eighty":14.380528,"marketCap":407779569},{"date":"2023-08-18","current":-177.90861,"twenty":-10.056396,"median":6.986782,"eighty":14.372659,"marketCap":383393054},{"date":"2023-08-25","current":-170.316697,"twenty":-10.152227,"median":6.952533,"eighty":14.334015,"marketCap":367032481},{"date":"2023-09-01","current":-172.895082,"twenty":-11.528064,"median":6.932503,"eighty":14.300431,"marketCap":372588902},{"date":"2023-09-08","current":-145.392302,"twenty":-12.623461,"median":6.905237,"eighty":14.272827,"marketCap":313320410},{"date":"2023-09-15","current":-149.25988,"twenty":-13.033575,"median":6.884571,"eighty":14.238323,"marketCap":321655042},{"date":"2023-09-22","current":-152.697728,"twenty":-13.168875,"median":6.85631,"eighty":14.225901,"marketCap":329063603},{"date":"2023-09-29","current":-152.41124,"twenty":-13.297434,"median":6.830215,"eighty":14.203358,"marketCap":328446223},{"date":"2023-10-06","current":-140.665261,"twenty":-13.435141,"median":6.802519,"eighty":14.183576,"marketCap":303133638},{"date":"2023-10-13","current":-136.797683,"twenty":-13.525181,"median":6.773134,"eighty":14.170234,"marketCap":294799007},{"date":"2023-10-20","current":-133.646323,"twenty":-13.584405,"median":6.745664,"eighty":14.158733,"marketCap":288007825},{"date":"2023-10-27","current":23.778109,"twenty":-13.598368,"median":6.745664,"eighty":14.167014,"marketCap":221707087},{"date":"2023-11-03","current":23.680524,"twenty":-13.577664,"median":6.774764,"eighty":14.236942,"marketCap":220797209},{"date":"2023-11-10","current":22.346868,"twenty":-13.547812,"median":6.803199,"eighty":14.372659,"marketCap":208362201},{"date":"2023-11-17","current":27.909189,"twenty":-13.52807,"median":6.836739,"eighty":14.430627,"marketCap":260225282},{"date":"2023-11-24","current":28.917563,"twenty":-13.525181,"median":6.85631,"eighty":14.437068,"marketCap":269627361},{"date":"2023-12-01","current":28.657338,"twenty":-13.505446,"median":6.884571,"eighty":14.497795,"marketCap":267201018},{"date":"2023-12-08","current":34.02449,"twenty":-13.470998,"median":6.905237,"eighty":14.573245,"marketCap":317244342},{"date":"2023-12-15","current":38.123042,"twenty":-13.460384,"median":6.940627,"eighty":14.631672,"marketCap":355459243},{"date":"2023-12-22","current":36.333991,"twenty":-13.435141,"median":6.954164,"eighty":14.677371,"marketCap":338778135},{"date":"2023-12-29","current":36.333991,"twenty":-13.404807,"median":6.970474,"eighty":14.704211,"marketCap":338778135},{"date":"2024-01-05","current":36.952027,"twenty":-13.397585,"median":6.991083,"eighty":14.719535,"marketCap":344540700},{"date":"2024-01-12","current":35.423202,"twenty":-13.386992,"median":7.016542,"eighty":14.743005,"marketCap":330285935},{"date":"2024-01-19","current":33.308869,"twenty":-13.35425,"median":7.040824,"eighty":14.762852,"marketCap":310571898},{"date":"2024-01-26","current":34.870223,"twenty":-13.297434,"median":7.052018,"eighty":14.7972,"marketCap":325129956},{"date":"2024-02-02","current":33.66668,"twenty":-13.239655,"median":7.119356,"eighty":14.868142,"marketCap":313908120},{"date":"2024-02-09","current":33.991961,"twenty":-13.181312,"median":7.140086,"eighty":14.902766,"marketCap":316941049},{"date":"2024-02-16","current":35.228033,"twenty":-13.176456,"median":7.204836,"eighty":15.530992,"marketCap":328466178},{"date":"2024-02-23","current":33.146228,"twenty":-13.171283,"median":7.231454,"eighty":16.007704,"marketCap":309055434},{"date":"2024-03-01","current":83.351439,"twenty":-13.159245,"median":7.254249,"eighty":16.944381,"marketCap":235301113},{"date":"2024-03-08","current":77.221075,"twenty":-13.139022,"median":7.397562,"eighty":17.504731,"marketCap":217995096},{"date":"2024-03-15","current":74.74742,"twenty":-13.092318,"median":7.453219,"eighty":17.739361,"marketCap":211011966},{"date":"2024-03-22","current":81.364368,"twenty":-13.05428,"median":7.477233,"eighty":17.972015,"marketCap":229691610},{"date":"2024-03-28","current":80.387995,"twenty":-12.971462,"median":7.50867,"eighty":18.290855,"marketCap":226935310},{"date":"2024-04-05","current":78.760708,"twenty":-12.865396,"median":7.544513,"eighty":18.783722,"marketCap":222341478},{"date":"2024-04-12","current":77.458878,"twenty":-12.701825,"median":7.583029,"eighty":19.185317,"marketCap":218666412},{"date":"2024-04-19","current":79.303137,"twenty":-12.659492,"median":7.648928,"eighty":20.171052,"marketCap":223872755},{"date":"2024-04-26","current":79.411623,"twenty":-12.569414,"median":7.683177,"eighty":20.718683,"marketCap":224179011},{"date":"2024-05-03","current":73.661874,"twenty":-12.562192,"median":7.736996,"eighty":20.882972,"marketCap":207947470},{"date":"2024-05-10","current":-9.41993,"twenty":-12.422559,"median":7.694593,"eighty":20.882972,"marketCap":227547821},{"date":"2024-05-17","current":-9.55939,"twenty":-10.931734,"median":7.658713,"eighty":20.755191,"marketCap":230916631},{"date":"2024-05-24","current":-9.064939,"twenty":-10.752052,"median":7.614015,"eighty":20.736937,"marketCap":218972668},{"date":"2024-05-31","current":-9.77492,"twenty":-10.40245,"median":7.561364,"eighty":20.736937,"marketCap":236122975},{"date":"2024-06-07","current":-10.751145,"twenty":-10.751145,"median":7.538026,"eighty":20.722334,"marketCap":259704647},{"date":"2024-06-14","current":-9.812955,"twenty":-10.735931,"median":7.489099,"eighty":20.685825,"marketCap":237041741},{"date":"2024-06-21","current":-13.023365,"twenty":-10.751689,"median":7.469528,"eighty":20.598203,"marketCap":314592404},{"date":"2024-06-28","current":-12.984217,"twenty":-10.787988,"median":7.459743,"eighty":20.532488,"marketCap":313646735},{"date":"2024-07-05","current":-13.036414,"twenty":-12.56797,"median":7.440172,"eighty":20.433914,"marketCap":314907627},{"date":"2024-07-12","current":-12.997266,"twenty":-12.950249,"median":7.23794,"eighty":20.433914,"marketCap":313961958},{"date":"2024-07-15","current":-13.036414,"twenty":-12.981666,"median":7.224968,"eighty":20.433914,"marketCap":314907627},{"date":"2024-08-02","current":-13.127761,"twenty":-13.007706,"median":7.086518,"eighty":20.725985,"marketCap":317114187},{"date":"2024-08-09","current":-7.228062,"twenty":-13.023365,"median":7.029992,"eighty":20.725985,"marketCap":307741975},{"date":"2024-08-16","current":-7.271344,"twenty":-13.023365,"median":6.970474,"eighty":20.725985,"marketCap":309584741},{"date":"2024-08-23","current":-7.26413,"twenty":-13.023365,"median":6.9205,"eighty":20.725985,"marketCap":309277614},{"date":"2024-08-30","current":-7.278558,"twenty":-13.023365,"median":6.879843,"eighty":20.725985,"marketCap":309891869},{"date":"2024-09-06","current":-7.206421,"twenty":-13.023365,"median":6.830215,"eighty":20.725985,"marketCap":306820592},{"date":"2024-09-13","current":-7.292985,"twenty":-13.023365,"median":6.773134,"eighty":20.725985,"marketCap":310506124},{"date":"2024-09-20","current":-7.242489,"twenty":-13.023365,"median":6.654179,"eighty":20.725985,"marketCap":308356230},{"date":"2024-09-27","current":-7.235276,"twenty":-13.023365,"median":6.602126,"eighty":20.725985,"marketCap":308049103},{"date":"2024-10-02","current":-7.155926,"twenty":-13.023365,"median":6.536302,"eighty":20.725985,"marketCap":304670698}],"updateTime":1785215194478},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627252371","title":"A Look At Jazz Pharmaceuticals (JAZZ) Valuation After New Neurology Data Plans At 2026 AAN Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627252371","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627252371?lang=en_us&edition=fundamental","pubTime":"2026-04-16 08:19","pubTimestamp":1776298759,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals (JAZZ) is drawing fresh attention after announcing six scientific presentations at the 2026 American Academy of Neurology meeting, which will feature new clinical data on Epidiolex across epilepsies and Xywav in narcolepsy.\nSee our latest analysis for Jazz Pharmaceuticals.\nThe shares have been firming up, with a 16.46% 90 day share price return and a 96.29% 1 year total shareholder return. This suggests recent enthusiasm is building around the pipeline news and broader...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/a-look-at-jazz-pharmaceuticals-jazz-valuation-after-new-neur","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/a-look-at-jazz-pharmaceuticals-jazz-valuation-after-new-neur","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0154245673.USD","LU0889565916.HKD","BK4007","BK4532","BK4178","IE00BN0W2T93.GBP","AAN","LU0154245756.USD","LU0320765992.SGD","JAZZ","BK4533","LU0823416689.USD","LU0109394709.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627446399","title":"Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627446399","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627446399?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:00","pubTimestamp":1776168000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., April  14, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/14/3273250/0/en/Grace-Therapeutics-Announces-Abstract-Highlighting-STRIVE-ON-Phase-3-Trial-Results-Accepted-for-Presentation-at-AAN-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861215975.USD","LENZ","LU1978683503.SGD","BK4585","BK4605","BK4108","IE00BZ199S13.USD","LU2298322129.HKD","BK4539","LU2360107325.USD","ON","LU1861214812.USD","ICU","LU1720051017.SGD","LU0724618433.USD","LU2357305700.SGD","BK4588","BK4141","LU1548497426.USD","LU0348723411.USD","BK4082","BK4512","LU0124384867.USD","RDI","BK4139","LU1861219969.SGD","LU1861220033.SGD","LU1720051108.HKD","IE00BFMHRM44.USD","LU1854103824.USD","LU1854104046.USD","AAN","BK4178","BK4007","IE00BD6J9T35.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626871411","title":"Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626871411","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626871411?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:00","pubTimestamp":1775736000,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., April  09, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for pat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270858/0/en/Kyverna-Therapeutics-to-Host-Conference-Call-on-New-Data-Across-Neuroimmunology-Franchise-at-AAN-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4178","BK4230","BK4588","BK4123","BK4139","HST","BK4181","CAR","KYTX","SOC","AAN","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4585","BK4218","BK4213","IE00B7SZL793.SGD","MG","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625956154","title":"Xenon to Unveil Phase 3 Azetukalner Data and Pipeline Advances at 2026 AAN Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2625956154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625956154?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:50","pubTimestamp":1775569829,"startTime":"0","endTime":"0","summary":"Xenon ( ($XENE) ) has issued an update. Xenon Pharmaceuticals will showcase new Phase 3 and long-term data for its lead candidate azetukalner in fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xenon-to-unveil-phase-3-azetukalner-data-and-pipeline-advances-at-2026-aan-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xenon-to-unveil-phase-3-azetukalner-data-and-pipeline-advances-at-2026-aan-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4178","AAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625095870","title":"Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2625095870","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625095870?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:30","pubTimestamp":1775565000,"startTime":"0","endTime":"0","summary":"Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal onset seizures Poster presentations also include long-te","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3269108/33485/en/Xenon-to-Highlight-Phase-3-X-TOLE2-Long-Term-Data-for-Azetukalner-in-Focal-Onset-Seizures-at-2026-AAN-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOCL","BK4178","AAN","BK4188","ASM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326723","title":"Press Release: AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326723?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:05","pubTimestamp":1774901100,"startTime":"0","endTime":"0","summary":"-- Announced positive initial comparative analytical results, confirming identical amino-acid sequencing and highly similar functional characteristics to BOTOX --. -- Reported positive FDA BPD Type 2a meeting, with FDA feedback providing a clear framework for advancing the comparative analytical plan for ABP-450 biosimilar program --. -- Strengthened balance sheet through $6 million PIPE financing and Daewoong note exchange, reducing outstanding debt by more than 90% --. -- Appointed John Bencich as Chief Financial Officer, adding significant capital markets and strategic leadership experience --. \"We've advanced the ABP-450 program with a positive FDA meeting and supportive initial comparative analytical results that reinforce our biosimilar development strategy,\" said Robert Bancroft, President and Chief Executive Officer of AEON. \"The Agency's feedback supports AEON's proposed framework for completing our analytical program and preparing for our next regulatory interaction. At the s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4178","AEON","LABU","BK4585","BK4232","BK4139","BK4022","AAN","R","BK4588","ABP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896695","title":"Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896695","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896695?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:02","pubTimestamp":1774555320,"startTime":"0","endTime":"0","summary":"Advancing first-to-market autoimmune CAR T opportunity in stiff person syndrome (SPS) with key launch preparation activities underway; BLA submission anticipated in 1H 2026  Progressing enrollment for","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263388/0/en/Kyverna-Therapeutics-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAN","BK4187","BK4023","BK4006","LD","IE00B7SZL793.SGD","RA","LU0963586101.USD","ACR","BK4139","CRS","IE0031619046.USD","KYTX","BK4022","BK4178","BK4588","HCP","IE00B19Z4B17.USD","IE00B66KJ199.SGD","BK4230","LU2065731478.USD","BK4585","IND","CAR","BK4110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621708166","title":"Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621708166","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621708166?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:30","pubTimestamp":1774265400,"startTime":"0","endTime":"0","summary":"Rese-cel myositis BLA submission on track for 2027 based on a 17-patient, single arm registrational cohort design, including an outpatient dosing option No-preconditioning program enrolling in lupus a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260280/0/en/Cabaletta-Bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4546","BK4187","CRS","BK4178","IE00B66KJ199.SGD","IE00B7SZL793.SGD","CABA","BK4006","IDMO","LU0963586101.USD","DM","BK4139","LU2065731478.USD","BK4161","AAN","IE00B19Z4B17.USD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618402496","title":"Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618402496","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618402496?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:00","pubTimestamp":1773054000,"startTime":"0","endTime":"0","summary":"X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo (p=0.000000000006","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251686/33485/en/Xenon-Announces-Positive-Topline-Data-from-Phase-3-X-TOLE2-Study-of-Azetukalner-in-Focal-Onset-Seizures-FOS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4138","LU0788109394.HKD","MPC","LU0300736492.USD","LU0368265418.SGD","LU0266512473.USD","AAN","LU0122376428.USD","LU0300736062.USD","IE00BSNM7G36.USD","LU0456854461.SGD","LU0266512127.USD","BK4178","BK4588","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617502314","title":"argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2617502314","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617502314?lang=en_us&edition=fundamental","pubTime":"2026-03-06 14:00","pubTimestamp":1772776800,"startTime":"0","endTime":"0","summary":"Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with ocular MG Additional data from ADAPT SERON – the largest study of pat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/06/3250804/0/en/argenx-to-Present-New-Data-at-2026-AAN-Annual-Meeting-that-Continue-to-Transform-Patient-Outcomes-in-MG-and-CIDP-and-Build-Upon-Strength-of-Pipeline.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","BK4588","IE0031619046.USD","LU0738911758.USD","AAN","BK4123","LU0545039389.USD","SMA","IE00B66KJ199.SGD","LU1003077747.HKD","LU1894683348.USD","MG","LU0949170772.SGD","IE00B19Z4B17.USD","BGSX","BK4178","BK4217","LU2500361329.USD","LU2637428348.USD","BK4585","LU1894683264.USD","LU0661504455.SGD","CMS","BK4208","LU2346227817.USD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617576000","title":"Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576000","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617576000?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:21","pubTimestamp":1772745660,"startTime":"0","endTime":"0","summary":"Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS) Oral presentation on updated KYSA-6 Phase 2 data in generalized myasthenia g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3250697/0/en/Kyverna-Therapeutics-to-Present-New-Data-from-Neuroimmunology-Franchise-at-AAN-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B66KJ199.SGD","MG","BK4022","BK4139","CAR","BK4123","KYTX","SOC","BK4230","IE00B7SZL793.SGD","BK4178","BK4213","AAN","IE00B19Z4B17.USD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612402045","title":"Press Release: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2612402045","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612402045?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:30","pubTimestamp":1771504200,"startTime":"0","endTime":"0","summary":"Two new drug applications  for ulixacaltamide in essential tremor  and for relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathies  have been submitted to the. Pre-launch activities for ulixacaltamide and relutrigine are underway and will accelerate through 2026. Essential3 results to be presented as an oral presentation at the American Academy of Neurology Annual Meeting. Cash and investments of $926 million as of December 31, 2025 and net proceeds of $621 million from January 2026 public offering fund operations into 2028. BOSTON, Feb. 19, 2026  -- Praxis Precision Medicines, Inc. , a fully integrated, leading central nervous system  precision neuroscience biopharmaceutical company, today provided a corporate update and reported financial results for the fourth quarter and full-year 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0889565916.HKD","IE00B2B36J28.USD","CNS","LU0320765992.SGD","BK4581","ET","BK4200","BK4555","LU0109394709.USD","BK4604","BK4585","BK4099","IE0009355771.USD","BK4590","BK4561","TM","ASO","BK4178","03160","IE00B4R5TH58.HKD","AAN","IE00BJT1NW94.SGD","PRAX","BK4144","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4135","IE00BJJMRZ35.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610960629","title":"Fundamental Research Sticks to Their Buy Rating for Aton Resources (AAN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610960629","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610960629?lang=en_us&edition=fundamental","pubTime":"2026-02-12 07:35","pubTimestamp":1770852934,"startTime":"0","endTime":"0","summary":"Fundamental Research analyst Siddharth Rajeev maintained a Buy rating on Aton Resources today and set a price target of C$1.08. According to TipRan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/fundamental-research-sticks-to-their-buy-rating-for-aton-resources-aan-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/fundamental-research-sticks-to-their-buy-rating-for-aton-resources-aan-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}]}}